MedTrace Logo

The Evolution and Management of Migraine Recurrence Beyond 24 Hours

NCT00754611 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-10-28

No results posted yet for this study

Summary

What is the course of migraine headache recurrence, how is it managed, what characteristics are associated with it, and how does it influence patient satisfaction with treatment?

Conditions

Sponsors & Collaborators

  • Endo Pharmaceuticals

    collaborator INDUSTRY

  • Rowan University

    lead OTHER

Principal Investigators

  • Loretta Mueller, DO · Rutgers, The State University of New Jersey

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00754611 on ClinicalTrials.gov